Reevaluating the Role of Corticosteroids in Septic Shock: An Updated Meta-Analysis of Randomized Controlled Trials

BioMed Research International

Volumn 2019, Issue , 2019, Pages

  Lian, X J ^a   Huang, D Z ^a   Cao, Y S ^b   Wei, Y X ^b   Lian, Z Z ^a   Qin, T H ^a   He, P C ^a   Liu, Y H ^a   Wang, S H ^a  

^a GUANGDONG PROVINCIAL PEOPLE'S HOSPITAL   (China)

^b SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID;

ALL CAUSE MORTALITY; CONTROLLED STUDY; GASTROINTESTINAL HEMORRHAGE; HOSPITAL MORTALITY; HUMAN; HYPERGLYCEMIA; INTENSIVE CARE UNIT; META ANALYSIS; MORTALITY; PREFERRED REPORTING ITEMS FOR SYSTEMATIC REVIEWS AND META-ANALYSES; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK FACTOR; SEPTIC SHOCK; SEQUENTIAL ANALYSIS; SUPERINFECTION; ARTIFICIAL VENTILATION; FEMALE; LENGTH OF STAY; MALE; MIDDLE AGED; PUBLISHING;

ADRENAL CORTEX HORMONES; FEMALE; HUMANS; INTENSIVE CARE UNITS; LENGTH OF STAY; MALE; MIDDLE AGED; PUBLICATION BIAS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESPIRATION, ARTIFICIAL; RISK FACTORS; SHOCK, SEPTIC;

EID: 85068255076     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2019/3175047     Document Type: Review

References (51)

1. M. Shankar-Hari, G. S. Phillips, M. L. Levy et al., "Developing a new defnition and assessing new clinical criteria for septic shock, " The Journal of the American Medical Association, vol. 315, no. 8, pp. 775-787, 2016.
2. D. Annane and T. Sharshar, "Cognitive decline afer sepsis, " The Lancet Respiratory Medicine, vol. 3, no. 1, pp. 61-69, 2015.
3. E. Rivers, B. Nguyen, S. Havstad et al., "Early goal-directed therapy in the treatment of severe sepsis and septic shock, " The New England Journal of Medicine, vol. 345, no. 19, pp. 1368-1377, 2001.
4. P. Caironi, G. Tognoni, S. Masson et al., "Albumin replacement in patients with severe sepsis or septic shock, " The New England Journal of Medicine, vol. 370, no. 15, pp. 1412-1421, 2014.
5. M. M. Levy, A. Rhodes, G. S. Phillips et al., "Surviving sepsis campaign: association between performance metrics and outcomes in a 7.5-year study, " Critical Care Medicine, vol. 43, no. 1, pp. 3-12, 2015.
6. D. Keh, S. Weber-Carstens, and O. Ahlers, "Adjunctive therapies in severe sepsis and septic shock: Current place of steroids, " Current Infectious Disease Reports, vol. 10, no. 5, pp. 354-361, 2008.
7. C. L. Sprung, P. V. Caralis, E. H. Marcial et al., "The efects of high-dose corticosteroids in patients with septic shock. a prospective, controlled study, " The New England Journal of Medicine, vol. 311, no. 18, pp. 1137-1143, 1984.
8. Veterans Administration Systemic Sepsis Cooperative Study Group, "Efect of high-dose glucocorticoid therapy on mortality in patients with clinical signs of systemic sepsis, " The New England Journal of Medicine, vol. 317, pp. 659-665, 1987.
9. R. C. Bone, C. J. Fisher Jr., T. P. Clemmer, G. J. Slotman, C. A. Metz, and R. A. Balk, "A controlled clinical trial of high-dose methylprednisolone in the treatment of severe sepsis and septic shock, " The New England Journal of Medicine, vol. 317, no. 11, pp. 653-658, 1987.
10. J. M. Luce, A. B. Montgomery, J. D. Marks, J. Turner, C. A. Metz, and J. F. Murray, "Inefectiveness of high-dose methylpred-nisolone in preventing parenchymal lung injury and improving mortality in patients with septic shock, " American Review of Respiratory Disease, vol. 138, no. 1, pp. 62-68, 1988.
11. D. Annane, V. Sebille, C. Charpentier, P. E. Bollaert, B. Francois, J. M. Korach et al., "Efect of treatment with low doses of hydrocortisone and fudrocortisone on mortality in patients with septic shock, " Journal of the American Medical Association, vol. 288, no. 7, pp. 862-871, 2002.
12. M. Oppert, R. Schindler, C. Husung et al., "Low-dose hydrocor-tisone improves shock reversal and reduces cytokine levels in early hyperdynamic septic shock, " Critical Care Medicine, vol. 33, no. 11, pp. 2457-2464, 2005.
13. C. L. Sprung, D. Annane, D. Keh et al., "Hydrocortisone therapy for patients with septic shock, " The New England Journal of Medicine, vol. 358, no. 2, pp. 111-124, 2008.
14. B. Gibbison, J. A. López-López, J. P. Higgins et al., "Corticos-teroids in septic shock: a systematic review and network meta-analysis, " Critical Care, vol. 21, no. 78, 2017.
15. B. Venkatesh, S. Finfer, J. Cohen, D. Rajbhandari, Y. Arabi, R. Bellomo et al., "Adjunctive glucocorticoid therapy in patients with septic shock, " The New England Journal of Medicine, 2018.
16. D. Annane, A. Renault, C. Brun-Buisson et al., "Hydrocortisone plus fudrocortisone for adults with septic shock, " The New England Journal of Medicine, vol. 378, no. 9, pp. 809-818, 2018.
17. D. Moher, L. Shamseer, M. Clarke et al., "Preferred report-ing items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement, " Systematic Reviews, vol. 4, no. 1, 2015.
18. W. Schumer, "Steroids in the treatment of clinical septic shock, " Annals of Surgery, vol. 184, no. 3, pp. 333-341, 1976.
19. D. Annane, E. Bellissant, P.-E. Bollaert et al., "Corticosteroids in the treatment of severe sepsis and septic shock in adults: a systematic review, " Journal of the American Medical Association, vol. 301, no. 22, pp. 2362-2375, 2009.
20. D. Annane, E. Bellissant, P. E. Bollaert, J. Briegel, D. Keh, and Y. Kupfer, "Corticosteroids for treating sepsis, " Cochrane Database of Systematic Reviews, vol. 2015, no. 12, Article ID CD002243, 2015.
21. J. L. Moran, P. L. Graham, S. Rocklif, and A. D. Bersten, "Updating the evidence for the role of corticosteroids in severe sepsis and septic shock: a bayesian meta-analytic perspective, " Critical Care, vol. 14, no. 4, article R134, 2010.
22. W. I. Sligl, D. A. Milner Jr., S. Sundar, W. Mphatswe, and S. R. Majumdar, "Safety and efcacy of corticosteroids for the treatment of septic shock: a systematic review and meta-analysis, " Clinical Infectious Diseases, vol. 49, no. 1, pp. 93-101, 2009.
23. C. Wang, J. Sun, J. Zheng et al., "Low-dose hydrocortisone therapy attenuates septic shock in adult patients but does not reduce 28-day mortality, " Anesthesia & Analgesia, vol. 118, no. 2, pp. 346-357, 2014.
24. J. Higgins and S. E. Green, Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0, The Cochrane Collaboration, Ed., vol. 5, Naunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 2011.
25. G. H. Guyatt, A. D. Oxman, G. E. Vist et al., "GRADE: an emerging consensus on rating quality of evidence and strength of recommendations, " British Medical Journal, vol. 336, no. 7650, pp. 924-926, 2008.
26. P.-E. Bollaert, C. Charpentier, B. Levy, M. Debouverie, G. Audibert, and A. Larcan, "Reversal of late septic shock with sup-raphysiologic doses of hydrocortisone, " Critical Care Medicine, vol. 26, no. 4, pp. 645-650, 1998.
27. A. C. Gordon, A. J. Mason, G. D. Perkins et al., "The interaction of vasopressin and corticosteroids in septic shock: A pilot randomized controlled trial, " Critical Care Medicine, vol. 42, no. 6, pp. 1325-1333, 2014.
28. P. Póvoa, J. I. F. Salluh, M. L. Martinez et al., "Clinical impact of stress dose steroids in patients with septic shock: insights from the PROWESS-Shock trial, " Critical Care, vol. 19, no. 193, 2015.
29. A. C. Gordon, A. J. Mason, N. Tirunavukkarasu et al., "Efect of early vasopressin vs norepinephrine on kidney failure in patients with septic shock: the VANISH randomized clinical trial, " Journal of the American Medical Association, vol. 316, no. 5, pp. 509-518, 2016.
30. J. Briegel, H. Forst, M. Haller et al., "Stress doses of hydro-cortisone reverse hyperdynamic septic shock: a prospective, randomized, double-blind, single-center study, " Critical Care Medicine, vol. 27, no. 4, pp. 723-732, 1999.
31. K. Chawla, Y. Kupfer, I. Goldman, and S. Tessler, "Hydrocorti-sone reverses refractory septic shock, " Critical Care Medicine, vol. 27, no. 1S, article 33A, 1999.
32. T. Mussack, J. Briegel, G. Schelling, P. Biberthaler, and M. Jochum, "Efect of stress doses of hydrocortisone on S-100B vs. interleukin-8 and polymorphonuclear elastase levels in human septic shock, " Clinical Chemistry and Laboratory Medicine, vol. 43, no. 3, pp. 259-268, 2005.
33. D. D. Cicarelli, J. E. Vieira, and F. E. M. Benseñor, "Early dex-amethasone treatment for septic shock patients: A prospective randomized clinical trial, " São Paulo Medical Journal, vol. 125, no. 4, pp. 237-241, 2007.
34. B. Hu, J. G. Li, H. Liang, Q. Zhou, Z. Yu, L. Li et al., "The efect of low-dose hydrocortisone on requirement of norepinephrine and lactate clearance in patients with refractory septic shock, " Zhongguo Wei Zhong Bing Ji Jiu Yi Xue, vol. 21, pp. 529-531, 2009.
35. Y. M. Arabi, A. Aljumah, O. Dabbagh et al., "Low-dose hydrocortisone in patients with cirrhosis and septic shock: a randomized controlled trial, " Canadian Medical Association Journal, vol. 182, no. 18, pp. 1971-1977, 2010.
36. S. Tongyoo, C. Permpikul, W. Mongkolpun et al., "Hydrocor-tisone treatment in early sepsis-associated acute respiratory distress syndrome: results of a randomized controlled trial, " Critical Care, vol. 20, no. 1, article 329, 2016.
37. Q. Q. Lv, X. H. Gu, Q. H. Chen, J. Q. Yu, and R. Q. Zheng, "Early initiation of low-dose hydrocortisone treatment for septic shock in adults: a randomized clinical trial, " The American Journal of Emergency Medicine, vol. 35, no. 12, pp. 1810-1814, 2017.
38. M. Talebi Doluee, M. Salehi, A. Mahmoudi Gharaee, M. Jalalyazdi, and H. Reihani, "The efect of physiologic dose of intravenous hydrocortisone in patients with refractory septic shock: a randomized control trial, " Journal of Emergency Practice and Trauma, vol. 4, no. 1, pp. 29-33, 2018.
39. C. Wang, J. Sun, J. Zheng et al., "Low-dose hydrocortisone therapy attenuates septic shock in adult patients but does not reduce 28-day mortality: a meta-analysis of randomized controlled trials, " Anesthesia & Analgesia, vol. 118, no. 2, pp. 346-357, 2014.
40. H. Levy, P.-F. Laterre, B. Bates, and R. L. Qualy, "Steroid use in PROWESS severe sepsis patients treated with drotrecogin alfa (activated), " Critical Care (London, England), vol. 9, no. 5, pp. R502-R507, 2005.
41. J. M. Raurich, J. A. Llompart-Pou, J. Ibáñez et al., "Low-dose steroid therapy does not afect hemodynamic response in septic shock patients, " Journal of Critical Care, vol. 22, no. 4, pp. 324-329, 2007.
42. Y. Zhu, Y. Wen, Q. Jiang, N. Guo, Y. Cai, and X. Shen, "The efectiveness and safety of corticosteroids therapy in adult criti-cal Ill patients with septic shock: a meta-analysis of randomized controlled trials, " Shock (Augusta, Ga.), 2018.
43. D. Keh, E. Trips, G. Marx et al., "Efect of hydrocortisone on development of shock among patients with severe sepsis: the HYPRESS randomized clinical trial, " Journal of the American Medical Association, vol. 316, no. 17, pp. 1775-1785, 2016.
44. S. L. Ryga°rd, E. Butler, A. Granholm et al., "Low-dose corticos-teroids for adult patients with septic shock: a systematic review with meta-analysis and trial sequential analysis, " Intensive Care Medicine, vol. 44, no. 7, pp. 1003-1016, 2018.
45. Study DB, "The efectiveness of hydrocortisone in the management of severe infections: a double-blind study, " Journal of the American Medical Association, vol. 183, no. 6, pp. 462-465, 1963.
46. S. Tandan, R. Guleria, and N. Gupta, Low dose steroids and adrenocortical insufciency in septic shock: a double-blind randomised controlled trial from India. Am J Respir Crit Care Med, 171, A43, 2005.
47. A. Torres, O. Sibila, M. Ferrer et al., "Efect of corticos-teroids on treatment failure among hospitalized patients with severe community-acquired pneumonia and high infamma-tory response: a randomized clinical trial, " Journal of the American Medical Association, vol. 313, no. 7, pp. 677-686, 2015.
48. M. Volbeda, J. Wetterslev, C. Gluud, J. G. Zijlstra, I. C. C. van der Horst, and F. Keus, "Glucocorticosteroids for sepsis: systematic review with meta-analysis and trial sequential analysis, " Intensive Care Medicine, vol. 41, no. 7, pp. 1220-1234, 2015.
49. B. Long and M. D. April, "Do corticosteroids improve mortality or shock reversal in patients with septic shock?" Annals of Emergency Medicine, vol. 71, no. 1, pp. 34-36, 2018.
50. M. Singer, C. S. Deutschman, C. Seymour et al., "The third international consensus defnitions for sepsis and septic shock (sepsis-3), " Journal of the American Medical Association, vol. 315, no. 8, pp. 801-810, 2016.
51. D. Annane, A. Cariou, V. Maxime et al., "Corticosteroid treatment and intensive insulin therapy for septic shock in adults: a randomized controlled trial, " Journal of the American Medical Association, vol. 303, no. 4, pp. 341-348, 2010.